Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TYR | P14679 | 1/20 | 0.41 |
| ▸ | CYP2A6 | P11509 | 4/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.41 |
| ▸ | ALDH5A1 | P51649 | 1/20 | 0.41 |
| ▸ | ABAT | P80404 | 1/20 | 0.41 |
| ▸ | APP | P05067 | 2/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.39 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.38 |
| ▸ | MAOA | P21397 | 1/20 | 0.38 |
| ▸ | MAOB | P27338 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 2/20 | 0.38 |
| ▸ | NPC1 | O15118 | 1/20 | 0.38 |
| ▸ | HPGD | P15428 | 1/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
| ▸ | RAB9A | P51151 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
| ▸ | KIF11 | P52732 | 1/20 | 0.37 |
| ▸ | CYP2A13 | Q16696 | 1/20 | 0.37 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.37 |
| ▸ | NR1H4 | Q96RI1 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18231551 | 0.92 | ALDH1A1 (0.48) | TYRCYP2A6HSD17B10ALDH5A1ABAT | |
| SCHEMBL12313043 | 0.92 | ALDH1A1 (0.48) | TYRCYP2A6HSD17B10ALDH5A1ABAT | |
| SCHEMBL19218156 | 0.88 | CYP2A6 (0.50) | TYRCYP2A6HSD17B10ALDH5A1ABAT | |
| SCHEMBL214899 | 0.85 | — | — | |
| SCHEMBL28553043 | 0.85 | CYP2A6 (0.52) | TYRCYP2A6HSD17B10ALDH5A1ABAT | |
| Hydrochloric Acid SCHEMBL28738883 | 0.83 | CYP2A6 (0.50) | TYRCYP2A6HSD17B10ALDH5A1ABAT | |
| SCHEMBL28362581 | 0.83 | CYP2A6 (0.50) | TYRCYP2A6HSD17B10ALDH5A1ABAT | |
| Ethylene SCHEMBL10458293 | 0.80 | TYR (0.48) | TYRCYP2A6HSD17B10ALDH5A1ABAT | |
| SCHEMBL791664 | 0.80 | MAPT (0.57) | HSD17B10APPALDH1A1MAPTNPC1 | |
| SCHEMBL9883874 | 0.79 | ALDH1A1 (0.59) | TYRCYP2A6HSD17B10ALDH5A1ABAT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2403670-B1 | STRUCTURED ORGANIC FILMS | XEROX CORP (US) | 2016-11-16 | — | — | EP | disclosed |
| US-9097995-B2 | Electronic devices comprising structured organic films | XEROX CORPORATION (US) | 2015-08-04 | — | — | US | disclosed |
| US-9097995-B2 | Electronic devices comprising structured organic films | XEROX CORPORATION (US) | 2015-08-04 | — | — | US | disclosed |
| US-8859171-B2 | Charge transport particles | XEROX CORPORATION (US) | 2014-10-14 | — | — | US | disclosed |
| US-8859171-B2 | Charge transport particles | XEROX CORPORATION (US) | 2014-10-14 | — | — | US | disclosed |
| US-8436130-B2 | Structured organic films having an added functionality | XEROX CORPORATION (US) | 2013-05-07 | — | — | US | disclosed |
| US-8394495-B2 | Composite structured organic films | XEROX CORPORATION (US) | 2013-03-12 | — | — | US | disclosed |
| US-8394495-B2 | Composite structured organic films | XEROX CORPORATION (US) | 2013-03-12 | — | — | US | disclosed |
| US-8357432-B2 | Mixed solvent process for preparing structured organic films | XEROX CORPORATION (US) | 2013-01-22 | — | — | US | disclosed |
| US-8334360-B2 | Structured organic films | XEROX CORPORATION (US) | 2012-12-18 | — | — | US | disclosed |
| WO-2010102018-A1 | MIXED SOLVENT PROCESS FOR PREPARING STRUCTURED ORGANIC FILMS | XEROX CORPORATION (US) | 2010-09-10 | — | — | WO | disclosed |
| WO-2010102036-A1 | STRUCTURED ORGANIC FILMS HAVING AN ADDED FUNCTIONALITY | XEROX CORPORATION (US) | 2010-09-10 | — | — | WO | disclosed |
| US-20100227157-A1 | COMPOSITE STRUCTURED ORGANIC FILMS | XEROX CORPORATION (US) | 2010-09-09 | — | — | US | disclosed |
| US-20100227081-A1 | MIXED SOLVENT PROCESS FOR PREPARING STRUCTURED ORGANIC FILMS | XEROX CORPORATION (US) | 2010-09-09 | — | — | US | disclosed |
| US-20100228025-A1 | STRUCTURED ORGANIC FILMS HAVING AN ADDED FUNCTIONALITY | XEROX CORPORATION (US) | 2010-09-09 | — | — | US | disclosed |
| US-20100227998-A1 | STRUCTURED ORGANIC FILMS | XEROX CORPORATION (US) | 2010-09-09 | — | — | US | disclosed |
| US-20100227998-A1 | STRUCTURED ORGANIC FILMS | XEROX CORPORATION (US) | 2010-09-09 | — | — | US | disclosed |
| US-20100227081-A1 | MIXED SOLVENT PROCESS FOR PREPARING STRUCTURED ORGANIC FILMS | XEROX CORPORATION (US) | 2010-09-09 | — | — | US | disclosed |
| US-20100224867-A1 | ELECTRONIC DEVICES COMPRISING STRUCTURED ORGANIC FILMS | XEROX CORPORATION (US) | 2010-09-09 | — | — | US | disclosed |
| US-20100227157-A1 | COMPOSITE STRUCTURED ORGANIC FILMS | XEROX CORPORATION (US) | 2010-09-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100224867-A1 | ELECTRONIC DEVICES COMPRISING STRUCTURED ORGANIC FILMS | EPCAM, EPHA6, EED | TYR 297/4885CYP2A6 1684/4885HSD17B10 4101/4885 |
| US-20100228025-A1 | STRUCTURED ORGANIC FILMS HAVING AN ADDED FUNCTIONALITY | VIM, PUF60, EPCAM | TYR 417/4885CYP2A6 3336/4885HSD17B10 4041/4885 |
| US-20100227998-A1 | STRUCTURED ORGANIC FILMS | VIM, PUF60, EPCAM | TYR 897/4885CYP2A6 2673/4885HSD17B10 3909/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.